摘要:
A power supply apparatus for an electric bicycle is disclosed. The apparatus may include i) a battery pack and ii) a keybox connected to the battery pack and controlling on/off operations of the power supply apparatus. The keybox may further include i) a key set configured to receive a key cylinder that is moveable according to the rotation of a key inserted into the key box, ii) a contact terminal that includes a first plurality of sub-terminals, iii) a terminal base including at least one second sub-terminal connectable to and detachable from at least one of the first sub-terminals and iv) a keybox case configured to receive the key set, the contact terminal, and the terminal base. The terminal base may have a plate shape with a polygonal periphery surface at least part of which contacts an inner portion of the keybox case.
摘要:
A power supply apparatus for an electric bicycle is disclosed. The apparatus may include i) a battery pack and ii) a keybox connected to the battery pack and controlling on/off operations of the power supply apparatus. The keybox may further include i) a key set configured to receive a key cylinder that is moveable according to the rotation of a key inserted into the key box, ii) a contact terminal that includes a first plurality of sub-terminals, iii) a terminal base including at least one second sub-terminal connectable to and detachable from at least one of the first sub-terminals and iv) a keybox case configured to receive the key set, the contact terminal, and the terminal base. The terminal base may have a plate shape with a polygonal periphery surface at least part of which contacts an inner portion of the keybox case.
摘要:
A substituted thieno pyrimidine compound of Formula 1, pharmaceutically acceptable salts and a pharmaceutical composition thereof is provided. The compound of Formula 1 exhibits superior inhibition activity against various protein kinases involved in growth factor signal transduction. The compound of Formula 1 and its compositions are useful for the prevention and treatment of diseases caused by abnormal cell growth including cancer.
摘要:
The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.
摘要:
The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.
摘要:
Disclosed is a method of fabricating a liquid crystal display (LCD) device in which a photosensitive film is selectively patterned using a half-tone mask, and then a portion of a passivation layer at a pixel area is selectively removed to secure an penetration path of a stripper. Additionally, a crack is generated on a conductive film formed on a photosensitive film pattern through a predetermined heat treatment to facilitate a lift-off process. Thus, the number of masks can be reduced to simplify the fabrication process of the LCD device and reduce fabrication costs.
摘要:
Disclosed is a method for processing messages in a mobile terminal having a communication service cutoff mode for disabling voice calls and message transmissions. The method includes the steps of storing one or more input messages when a user presses a key to send the messages during the communication service cutoff mode and automatically sending each stored message to a corresponding recipient upon cancellation of the communication service cutoff mode. The messages input during the communication service cutoff mode are automatically sent to corresponding recipients upon cancellation of that mode, thereby improving user convenience.
摘要:
The present invention relates to a plasma display panel, and more particularly, to a method and apparatus for driving a plasma display panel. According to a first embodiment of the present invention, there is provided a method for driving a PDP including the steps of dividing two frame data items into three frame data items; and providing the divided frame data items to the PDP. According to a first embodiment of the present invention, there is provided a method for driving a PDP including the steps of dividing two frame data items into three frame data items; and providing the divided frame data items to the PDP. The method and apparatus for driving a PDP according to the present invention can reduce large area flicker and dynamic false contour noise in a high-resolution PDP.
摘要:
An apparatus and method for providing traceback connection using a connection redirection technique are provided. A packet blocking unit blocks an attack packet transmitted to the system and a first response packet output from the system in response to the attack packet, if a system attack sensing signal is received. A response packet generation unit generates a second response packet into which a watermark is inserted, in response to the attack packet, and transmits the second response packet to a system corresponding to the source address of the attack packet. A path traceback unit receives a detection packet containing transmission path information of the second response packet from a system existing on a transmission path of the second response packet, and based on the received detection packet, traces back the transmission path of the second response packet and identifies the location of the attacker system. According to the apparatus and method, even when an attacker attacks a predetermined system via a plurality of systems, the actual location of the attacker system can be traced back fast and accurately and damage of the victim system can be minimized.
摘要:
The present invention relates to a novel bicyclic heteroaryl derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof having an improved inhibitory activity for protein kinases, and a pharmaceutical composition for preventing or treating an abnormal cell growth disorder comprising same as an active ingredient.